CDD MEDICAL
ActiveSummary
CDD MEDICAL has been active since 2004 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €329,483 and a net result of €9,592. Equity has been growing by about 3.5% per year since 2023. The computed 12-month bankruptcy probability is 0.9% (low).
Overview
Official details
Source: KBO- Status
- Active since 20-01-2004 Normal situation
- Legal form
- Private limited company (pre-2019)
- Activity
- No activity registered in the KBO
- Establishment unit
- 2.135.609.804 1000 Brussel, since 20-01-2004
- Financial year end
- 31 December
- Peppol
- Not found in the Peppol Directory
Board and ownership
- DOUALA MOUTENG OLESSA HORTENSE CAROL ELEONOREDirector · since 23-12-2003
Financial position
- Bankruptcy probabilitywithin 12 months
- 0.9%
- Gross margin
- €13,084
- ▼ 24.0%
- Turnover
- ≈ €100,000
- estimated
- Profit
- €9,592
- ▼ 23.4%
- Equity
- €329,483
- ▲ 3.0%
- Total assets
- €345,977
- ▲ 5.4%
- 2025 accounts filed 11 days after the deadline
Score breakdownraises riskLiquidity: current ratio 20.98Last filed accounts filed 11 days late; 2 of the last 3 accounts latelowers riskSize: total assets €345,977Equity €329,483 (95.2% of total assets)Show the evidence
Checked score
About 9 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (no NACE code, micro). It does better than 81% of them on solvency, 95% on liquidity, 33% on profitability and 57% on growth.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
The company filed its last 3 accounts on average 252 days after the deadline. The Belgian median for financial year 2024 was 4 days before the deadline, and 38% of all filings were late.
Searched, nothing found (2)
Key facts about CDD MEDICAL
- What is the company number of CDD MEDICAL?
- The company number of CDD MEDICAL is 0862.797.083. The VAT number is the same number with BE in front: BE 0862.797.083.
- What is the legal form of CDD MEDICAL?
- The legal form of CDD MEDICAL is Private limited company (pre-2019) (BVBA).
- When was CDD MEDICAL founded?
- CDD MEDICAL was founded on 20-01-2004.
- Is CDD MEDICAL still active?
- Yes, CDD MEDICAL is an active enterprise in the KBO register.Company details
- What is the turnover of CDD MEDICAL?
- The turnover in financial year 2025 is ≈ €100,000. This figure is estimated from the gross margin of €13,084 and 6,330 comparable companies of the same size. It probably lies between €46,000 and €240,000. It is a rough estimate.Financials
- Is CDD MEDICAL profitable?
- In financial year 2025, CDD MEDICAL made a profit of €9,592.
- Where can I find the annual accounts of CDD MEDICAL?
- CDD MEDICAL filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of CDD MEDICAL due?
- CDD MEDICAL must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
See how customers, suppliers and banks see your own company and what to improve first.